Filtered By:
Infectious Disease: COVID-19
Countries: Spain Health
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 141 results found since Jan 2013.
COVID-19 pandemic on coronary artery and cerebrovascular diseases in Southern Spain: interrupted time series analysis
CONCLUSIONS: A decline in AMI and CVD daily hospital admissions during the first and second wave of COVID-19 pandemic was noted. Gender differences were observed, but no clear impact was observed in percutaneous interventions.PMID:37070925 | DOI:10.26355/eurrev_202304_31955
Source: European Review for Medical and Pharmacological Sciences - April 18, 2023 Category: Drugs & Pharmacology Authors: F J Rodr íguez-Cortés J E Jim énez-Hornero J F Alcal á-Diaz R M Mi ñarro-Del Moral J L Romero-Cabrera R Manfredini M A Rodr íguez-Borrego P J L ópez-Soto Source Type: research
Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
Lancet Respir Med. 2022 Oct 10:S2213-2600(22)00298-3. doi: 10.1016/S2213-2600(22)00298-3. Online ahead of print.ABSTRACTBACKGROUND: COVID-19 disease is accompanied by a dysregulated immune response and hypercoagulability. The Anti-Coronavirus Therapies (ACT) inpatient trial aimed to evaluate anti-inflammatory therapy with colchicine and antithrombotic therapy with the combination of rivaroxaban and aspirin for prevention of disease progression in patients hospitalised with COVID-19.METHODS: The ACT inpatient, open-label, 2 × 2 factorial, randomised, controlled trial was done at 62 clinical centres in 11 countries. Patient...
Source: Respiratory Care - October 13, 2022 Category: Respiratory Medicine Authors: John W Eikelboom Sanjit S Jolly Emilie P Belley-Cote Richard P Whitlock Sumathy Rangarajan Lizhen Xu Laura Heenan Shrikant I Bangdiwala Maria Luz Diaz Rafael Diaz Afzalhussein Yusufali Sanjib Kumar Sharma Wadea M Tarhuni Mohamed Hassany Alvaro Avezum Will Source Type: research
The COVID-19 pandemic effect on the prehospital Madrid stroke code metrics and diagnostic accuracy
by Nicol ás Riera-López, Andrea Gaetano-Gil, José Martínez-Gómez, Nuria Rodríguez-Rodil, Borja M. Fernández-Félix, Jorge Rodríguez-Pardo, Carmen Cuadrado-Hernández, Emmanuel Pelayo Martínez-González, Alicia Villar-Arias, Fátima Gutiérrez-Sánchez, Pablo Busca-Ostolaza, Eduardo Montero-Ruiz, Exu perio Díez-Tejedor, Javier Zamora, Blanca Fuentes-Gimeno, on behalf of the Madrid Stroke Network
BackgroundOnly very few studies have investigated the effect of the COVID-19 pandemic on the pre-hospital stroke code protocol. During the first wave, Spain was one of the most affected countries by the SARS-CoV-2 coronavi...
Source: PLoS One - October 10, 2022 Category: Biomedical Science Authors: Nicol ás Riera-López Source Type: research
COVID-19 Can Increase Risk of Psychiatric Disorders for Up to Two Years
The increased risk of depression and anxiety that patients experience after developing COVID-19 typically subsides within two months, according to astudy published yesterday inThe Lancet Psychiatry. However, patients may have an elevated risk for developing other psychiatric and neurological conditions, such as psychosis, brain fog, and seizures, for up to two years after their infections.“The results have important implications for patients and health services as it suggests new cases of neurological conditions linked to COVID-19 infection are likely to occur for a considerable time after the pandemic has subsided,” s...
Source: Psychiatr News - August 18, 2022 Category: Psychiatry Tags: adults anxiety brain fog children COVID-19 delta dementia depression older adults omicron psychotic disorder seizures The Lancet Psychiatry Source Type: research
Ischaemic stroke due to basilar artery occlusion in a puerperal patient with SARS-CoV-2 infection
CONCLUSION: Severe SARS-CoV-2 disease results in a prothrombotic state that correlates with the prognosis of the disease. The last trimester of pregnancy and the puerperium are known prothrombotic risk factors. Recommendations for anticoagulation management in pregnant patients with COVID-19 are based on limited evidence. This is the first case to be published in Spain involving cerebral arterial thrombosis in a pregnant patient with SARS-CoV-2 infection.PMID:35866535 | DOI:10.33588/rn.7504.2021373
Source: Revista de Neurologia - July 22, 2022 Category: Neurology Authors: M G ómez-Martí V Bosch ín F Puchades A Cerd án A Cunquero F Sanz J J Tamarit Source Type: research
Risk of thrombotic events and other complications in anticoagulant users infected with SARS-CoV-2: an observational cohort study in primary health care in SIDIAP (Catalonia, Spain)
CONCLUSIONS: OAC users in our study had more comorbidities and were older than non-users, well known risks for hospitalization being confirmed with our results. We also found in our study that OAC exposure was not associated to an increased risk in the mortality rate, and it was associated with higher risks of hospital admission and thromboembolic events, although we cannot assess the effect of the interventions applied during hospital admission on the outcomes studied, as our database is a PHC database.TRIAL REGISTRATION: EUPAS register: EUPAS37205 .PMID:35676639 | PMC:PMC9174624 | DOI:10.1186/s12875-022-01752-5
Source: Primary Care - June 8, 2022 Category: Primary Care Authors: Maria Giner-Soriano Ainhoa Gomez-Lumbreras Cristina Vedia Dan Ouchi Rosa Morros Source Type: research
Impacts of changes in environmental exposures and health behaviours due to the COVID-19 pandemic on cardiovascular and mental health: A comparison of Barcelona, Vienna, and Stockholm
Environ Pollut. 2022 Mar 29:119124. doi: 10.1016/j.envpol.2022.119124. Online ahead of print.ABSTRACTResponses to COVID-19 altered environmental exposures and health behaviours associated with non-communicable diseases. We aimed to (1) quantify changes in nitrogen dioxide (NO2), noise, physical activity, and greenspace visits associated with COVID-19 policies in the spring of 2020 in Barcelona (Spain), Vienna (Austria), and Stockholm (Sweden), and (2) estimated the number of additional and prevented diagnoses of myocardial infarction (MI), stroke, depression, and anxiety based on these changes. We calculated differences in...
Source: Environmental Pollution - April 3, 2022 Category: Environmental Health Authors: Sarah Koch Sasha Khomenko Marta Cirach M ònica Ubalde-Lopez Sacha Baclet Carolyn Daher Laura Hidalgo Mare L õhmus Debora Rizzuto Romain Rumpler Yusak Susilo Siddharth Venkataraman Sandra Wegener Gregory A Wellenius James Woodcock Mark Nieuwenhuijsen Source Type: research
